Beryl Drugs Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 5.47 | 3.85 | 5.16 |
| Operating Expense | 4.13 | 4.05 | 4.42 |
| Net Profit | 0.56 | -0.17 | 0.01 |
| Net Profit Margin | 10.24% | -4.42% | 0.19% |
| Earning Per Share | 1.11 | -0.33 | 0.02 |
| EBIDTA | 1.06 | 0.06 | 0.59 |
| Effective Tax Rate | 2.24% | 90.00% | 15.07% |
Particulars
Mar 2026
Revenue5.47
Operating Expense4.13
Net Profit0.56
Net Profit Margin10.24
Earning Per Share1.11
EBIDTA1.06
Effective Tax Rate2.24
